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Abstract
Epidemiological studies have demonstrated protective effects of breast-feeding on childhood obesity. Differences between human milk and
infant milk formula (IMF) in dietary lipid structure may contribute to this effect. In our mouse model, feeding a diet containing large lipid
droplets coated with phospholipids (PL) (Nuturis®; PL of milk fat globule membrane (MFGM) fraction origin) in early life protected against
excessive body fat accumulation following a diet challenge in adult life. We now set out to determine the relevance of increased droplet size
and/or MFGM lipid droplet coating to the observed anti-obesogenic effects in adult life. From day 16 to 42, male mouse pups were exposed to
diets with small (S) or large (L) lipid droplets (0·3 v. 2·9 µm average mode diameter, respectively), either without MFGM or with MFGM coating
around the lipid droplet, resulting in four groups: S (control diet), L, Scoating and Lcoating (Nuturis® IMF diet). Mice were subsequently
challenged with a Western-style diet until dissection at postnatal day 98. A non-challenged group served as reference (REF). We repeatedly
determined body composition between postnatal day 42 and 98. At day 98 plasma and gene expression measurements were performed. Only
the Nuturis® IMF diet (Lcoating) in early life containing MFGM-coated large lipid droplets reduced body fat mass to a level comparable with the
REF group. These data support the notion that the structural aspects of lipids in human milk, for example, both lipid droplet size as well as the
MFGM coating, may contribute to its reported protective effect against obesity in later life.
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Breast-feeding is associated with a moderate, but consistent,
reduction in the risk of childhood obesity and metabolic disease
in later life(1–5). Speciﬁc aspects of breast-feeding such as
feeding behaviour and its unique nutritional composition may
contribute to this long-term protective effect. Human milk (HM)
contains several biologically active compounds such as oligo-
saccharides, hormones and growth factors that are not present
in infant milk formula (IMF), supporting optimal growth and
development(6–9). Moreover, HM lipids have a distinct physical
structure composed of large lipid droplets (average mode
diameter of 4 µm) consisting of a TAG core enveloped by a
tri-layer of membranes, the native milk fat globule membrane
(MFGM)(10–12). MFGM components are secreted by the epithe-
lial cells of the mammary gland and consist of phospholipids
and sphingolipids, membrane-speciﬁc proteins, enzymes,
cholesterol, glycoproteins and vitamins. In contrast, the
diameter of lipid droplets in standard IMF is about 0·3–1·0 μm
and is not surrounded by a membrane, due to the industrial
processing procedures to achieve stable and reproducible end
products. The IMF fat globules mainly consist of TAG derived
from plant oils and have milk proteins adhering to the surface,
with or without small amounts phospholipids (PL)(13–16).
Several studies have indicated that dietary exposure to a
MFGM lipid-containing product may have beneﬁcial effects.
Clinical intervention studies with MFGM products in adults have
shown long-term anti-carcinogenic effects, hypocholester-
olaemic effects, suppression of multiple sclerosis and improved
learning and cognitive performance after consuming the MFGM
extract (reviewed by Spitsberg(17)). Dietary exposure to MFGM
lipid product in early life may have beneﬁcial effects on growth
and (cognitive) development in rodents and infants(18,19).
Timby et al.(19,20) showed that infants fed a low-energy, low-
protein, MFGM-enriched formula showed cognitive develop-
ment and serum cholesterol concentrations more similar to
Abbreviations: %FM, percentage of fat mass; BW, body weight; FM, fat mass; HM, human milk; IMF, infant milk formula; L, large droplet; LSD, least square
difference; mest/peg1, mesoderm-speciﬁc transcript/paternal expressed gene 1; MFGM, milk fat globule membrane; PL, phospholipids; PN, postnatal;
qPCR, quantitative PCR; REF, reference; RP, retroperitoneal; S, small droplet; WAT, white adipose tissue; WSD, Western-style diet.
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those of breast-fed infants at 12 months of age as compared
with a standard IMF. The composition of MFGM has been
shown to affect pancreatic gastric lipase activity and lipase
interaction, cholesterol availability, lipid absorption and
absorption of bile salts(13,14,19). However, no growth or asso-
ciated metabolic effects of MFGM have so far been reported in
clinical studies.
We hypothesised that in particular the physical structure of
dietary lipids in early life contributes to a healthy development
of body composition at longer term via effects on growth and
metabolic development during infancy. It has been clearly
shown that dietary lipid structure affects lipolysis and the
metabolic fate of fatty acids (FA) due to distinct differences in
lipid digestion and absorption kinetics(21,22). Any difference in
postprandial lipid handling can impact lipid availability for
the development of metabolic organs. This in turn could
programme metabolic homoeostasis, energy balance and
metabolic response with potential impact on later life health.
We have previously shown that exposing young mice to a
concept diet (Nuturis®; Nutricia Research) containing PL
derived from the MFGM fraction, coated around large lipid
droplets, prevented fat accumulation and improved metabolic
proﬁle in adulthood(23,24). These data indicated that exposure to
an altered dietary lipid structure in early life may be a key
determinant of later life metabolic health. Thus far, however, it
is not known how speciﬁc aspects of the Nuturis® concept, that
is, lipid droplet size and/or coating, may contribute to these
later life beneﬁcial effects. The objective of the present study
was to determine whether large droplet size and/or coating are
responsible for the previously found long-term protective
effects against adult adiposity. To this end, we used a validated
mouse model for nutritional programming(25) in which young
pre-weaning mice were exposed to intervention diets com-
prising different features of the Nuturis® concept. After the early
diet intervention, all mice were switched to a Western-style diet
(WSD) and body composition development was monitored.
Methods
Animals and study design
All experimental procedures were approved by the Animal
Experimental Committee (DEC Consult) and complied with the
principles of good laboratory animal care. The animals were
housed at facilities of the Wageningen University and Research
Centre in a 12 h light–12 h dark cycle (light on 06.00 hours=
Zeitgeber time 0 h). Room temperature and humidity were
controlled (21 (SEM 2)°C and 50 (SEM 5)%, respectively). During
the entire protocol, food and water were available ad libitum.
Between postnatal (PN) day 42 and 98, food intake was
measured per cage and body weight (BW) was determined
per litter before weaning and individually after weaning twice a
week. Male and female C57BL/6J mice were time mated. Dams
were assigned to the American Institute of Nutrition-93
(AIN93G) diet during pregnancy and lactation. After birth, lit-
ters were culled to four male and two female pups and ran-
domly cross-randomised. Litters were randomly allocated to
one of the experimental diets (see below) from PN16 until
PN42. At weaning on PN21, male pups were housed in pairs
and continued on their respective diets until PN42. From PN42
until dissection at PN98, animals were exposed to a WSD (20%,
w/w fat) (Fig. 1). To control for the effects of the WSD challenge
in adolescence and adulthood, a reference (REF) group was
included, which was fed the control IMF diet from PN15 to
PN42 and the AIN93M diet from PN42 to PN98.
Experimental diets
All experimental diets were semi-synthetic (Research Diet
Services; Table 1) and had macronutrient and micronutrient
compositions according to the AIN formulation of AIN93G-
puriﬁed diets for laboratory rodents. The experimental diets
contained 28·3%, w/w IMF powder complemented with protein
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Fig. 1. Study design from postnatal day (PN) 0–PN98. S, small droplets=Nutrilon; L, large droplets; Scoating, small droplets coated by milk fat globule membrane
(MFGM); Lcoating, large droplets coated by MFGM=Nuturis®; DEXA, dual-energy X-ray absorptiometry; IMF, infant milk formula; AIN93M, American Institute of
Nutrition-93.
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The fat fraction was completely derived from the IMF. The
detailed composition and processing procedure of the diets
have been described previously(24). The diets were provided as
a dough in order to preserve the lipid structure of the products.
The experimental diets differed according to lipid droplet size
(small (S) v. large (L)) and presence or absence of MFGM as
lipid droplet coating: S (control IMF diet), L, Scoating and Lcoating
(Nuturis® IMF diet). The MFGM originated from butter serum
(SM 2; Corman Food Industry). In the production of anhydrous
milk fat from cream, the aqueous streams are a by-product, rich
in milk PL, present as MFGM fragments and referred to as butter
serum(26).
The oil blend of IMF was a mixture of oils such as rapeseed,
sunﬂower, ﬁsh, coconut and palm oil. After IMF production,
protein, lactose, lipid, PL concentrations and droplet size were
measured (Table 1). The protein content was analysed
according to the Dumas principle; the used N-factor was 6·25
(ISO14891 IDF 185, 2002). The lactose content was determined
by an enzymatic method based on Nederlands Normalisatie-
Instituut (NEN) 6853, 1989. Lipid content was determined
according to the Van Gulik method (ISO11870, 2000). PL con-
tent was analysed with P-NMR by Spectral Services. The particle
size distribution was determined by laser light scattering. The
measurements were performed at 20°C, using a refractive index
for fat of 1·46 and 0·01 absorption. The refractive index for the
dispersant (water) of 1·33 was used (Mastersizer 2000, Hydro
2000G; Malvern Instruments Limited).
The WSD consisted of 20%, w/w fat (3%, w/w soya oil; 17%,
w/w lard and 0·1%, w/w cholesterol).
Body composition
Body composition was repeatedly measured between PN42 and
98 by dual-energy X-ray absorptiometry scan under general
anaesthesia (isoﬂurane–N2O–O2) using a PIXImus imager (GE
Lunar). Relative fat mass (FM) was calculated as the percentage FM
(%FM) of total BW. Between PN42 and PN98, BW, lean body mass
(LBM), FM and %FM gain (δBW, δLBM, δFM and δ%FM, respec-
tively) were calculated by subtracting PN42 values from PN98.
Blood sampling and dissection
On PN98, mice were anaesthetised (isoﬂurane–N2O–O2)
after fasting overnight and killed by bleeding (eye extraction)
and cervical dislocation. Blood samples were collected in
K3EDTA-coated 1-ml micro tubes. Plasma was obtained by
centrifugation at 1350 g for 12min at 4°C and stored at −80°C.
The liver, pancreas, musculus tibialis and brain as well as
epididymal (EPI), retroperitoneal (RP), perirenal (peri) and
inguinal (ING) white adipose tissue (WAT) depots were dis-
sected, weighed, snap-frozen in liquid N2 and stored at −80°C.
Plasma analyses
Plasma glucose concentration was measured colorimetrically
(glucose oxidase-phenol and 4 aminophenazone (GOD-PAP)
method; Roche Diagnostics) and analysed using a micro plate
imaging system (Bio-Rad Laboratories, Inc.). Insulin concentration
was measured using ELISA (DRG) according to the manufacturer’s
protocol. Homoeostasis model assessment of insulin resistance
as calculated from fasting plasma glucose and insulin concentra-
tions (glucose (mmol/l)× insulin (pmol/l)/22·5) as an indirect
measure of insulin sensitivity. Total cholesterol, HDL-cholesterol,
LDL-cholesterol, VLDL-cholesterol and TAG concentrations were
determined colorimetrically after enzymatic conversion using a
Roche Hitachi 717 analyzer (Reinier de Graaf Laboratory).
Gene expression in retroperitoneal white adipose tissue
Total RNA was isolated from the RP WAT using Trizol–chloroform
(Invitrogen) and puriﬁed using a RNeasy mini kit (Qiagen Benelux
B.V.). Contaminating genomic DNA was removed with the RNase-
free DNase set (Qiagen Benelux B.V.). Quality and quantity of
RNA were determined by NanoDrop 2000 (Thermo Scientiﬁc)
and Bioanalyzer (Agilent). Complementary DNA (cDNA) was
synthesised using the iScript cDNA synthesis kit (Bio-Rad)
according to the manufacturer’s instructions; 9·4ng of RP fat
depot was used as input for each quantitative PCR (qPCR) reac-
tion. 5× Hot FIREPol Evagreen qPCR mix Plus (Bio-Connect) was
used according to the manufacturer’s instructions and qPCR was
accomplished with a 7900HT Fast Real-Time PCR System (Applied
Biosystems). Leptin (marker adiposity), mesoderm-speciﬁc tran-
script/paternal expressed gene 1 (mest/peg1; marker adipocyte
size) and preadipocyte factor 1 (Pref1; marker preadipocytes)
mRNA expressions were measured. Normalisation of qPCR data
was achieved using qBase PLUS (Biogazelle). qBase is a free
programme for the analysis of qPCR data, and for this experiment
several housekeeping genes (calnexin, ribosomal protein gene
L19, ribosomal protein S29) were used to normalise the qPCR
data. For detailed description, see the published article of
Hellemans et al.(27). The primer sequences are depicted in Table 2.
Statistical analyses
Statistical analyses were performed using SPSS 19.0 (SPSS
Benelux). Effects of diets on body composition, organ weights,
plasma and gene expression parameters were analysed using
mixed effects regression models, including droplet size and
coating and size by coating interaction as ﬁxed effects. In all
regression models, the correlation among animals within the
same cage was accounted for by their sharing a common ran-
dom effect. Pairwise comparisons were adjusted for multiple
comparisons, using the least square difference (LSD) approach.
Table 1. Protein, lactose, lipid and phospholipid (PL) content (g), ana-
lysed per 100 g powder. Average of lipid droplet size (μm) of the different
diets based on repeated productions
Protein Lactose Lipids PL Mode* % 2–12 μm†
S 10·4 50·7 25·4 0·05 0·4 4·8
L 9·5 50·2 25·4 0·05 4·4 52·7
Scoating 10·1 47·3 24·9 0·4 0·4 2·9
Lcoating 9·7 48·3 25·4 0·5 3·2 56·0
S, small droplets; L, large droplets; Scoating, small droplets coated by milk fat globule
membrane (MFGM); Lcoating, large droplets coated by MFGM.
* Peak diameter of particle size distribution.
† Sum volume of particles of 2–12mm (% total volume of all particles).
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Data are shown as mean values with their standard errors.
Differences were considered signiﬁcant when P< 0·05 and a
trend was deﬁned at P< 0·1.
Results
Programming of adult food intake and body composition
by dietary lipid structure
Average energy intake from PN42 to PN98 was comparable
between groups. To control for the effects of the WSD chal-
lenge, a REF group was included. At day 98, BW, LBM, FM and
%FM of the REF group were lower than all other groups fed
WSD (Fig. 2). However, FM of REF mice was signiﬁcantly lower
(approximately 64%) compared with S, L and Scoating groups fed
the WSD, but not signiﬁcantly different from FM found in the
Lcoating group that showed comparable FM gain with the REF
group.
At day 98, mice that received the concept diet containing
MFGM coated around large lipid droplets (Lcoating, Nuturis®)
showed signiﬁcantly reduced FM compared with a diet con-
taining small lipid droplets with comparable MFGM surface
coating (P= 0·05; Fig. 2; analysed using LSD) and a trend when
compared with a diet containing large lipid droplets only
(FM gain P= 0·072 and %FM P= 0·059, respectively).
BW was not signiﬁcantly different between the four groups,
although trends supported the above-summarised differences:
BW (F= 2161, P= 0·157), LBM (F= 1·074, P= 0·312), FM
(F= 3·620, P= 0·072) and %FM (F= 3·646, P= 0·071) at PN98
(analysed by a mixed effect regression model).
Programming effects of dietary lipid structure in early-life
diet on adult organ weights
The weight of the EPI fat depot was lower in mice fed Lcoating in
early life compared with small lipid droplets with or without
MFGM surface coating (S, P= 0·045 and Scoating, P= 0·05,
respectively; Table 3) and a trend was observed when com-
pared with large lipid droplets only (L; P= 0·071). The ING fat
depot weight was lower in Lcoating mice (Nuturis®) compared
with Scoating (P= 0·018; analysed using LSD) and a trend was
observed when compared with large lipid droplets only
(L; P= 0·066). The weight of the peri fat depot was decreased in
Lcoating mice compared with L (P= 0·049) and a trend was
detected when compared with Scoating (P= 0·053). The weight
of the liver was higher in Scoating and L compared with
S (P= 0·047 and P= 0·021, respectively) and a trend was
observed when compared with Lcoating (P= 0·073).
Effects of dietary lipid structure in early-life diet on adult
plasma parameters
At day 98, plasma parameters were only moderately affected by
the WSD itself, as indicated by the results of the REF group: only
glucose concentrations were 44% lower in REF mice fed a
standard rodent diet compared with the groups fed WSD
(P< 0·05, data not shown). The multivariate analysis results are
depicted in the supplements (online Supplementary Table S1;
analysed using LSD).
Programming of markers for adiposity, adipocyte size and
cell differentiation
At day 98, leptin expression was signiﬁcantly lower in the
Lcoating group compared with the S control group (P= 0·023;
Fig. 3(a); analysed using LSD). Besides, mest/peg1 expression in
Lcoating (Nuturis®) was decreased compared with L following the
WSD challenge (P= 0·043; Fig. 3(b)), but only a trend was seen
for lower mest/peg1 expression in Lcoating compared with Scoating
and S (P= 0·053 and P= 0·051, respectively).
Discussion
The present study aimed to determine whether providing a diet
in early life containing large lipid droplets, MFGM as lipid
droplet coating or their combination, was responsible for the
long-term protective effect against adiposity in a mouse model.
Our results clearly indicate that the combination of a large
droplet size and MFGM present as a lipid droplet coating was
essential for prevention of excessive body FM accumulation in
adult life. Neither an increase in droplet size alone nor MGFM
coating of small lipid droplets exerted any beneﬁcial program-
ming of adult body composition. These data suggest that the
complex structure of large lipid droplet size consisting of a TAG
core surrounded by a trimembrane layer as present in HM may
signiﬁcantly contribute to its reported protective effect against
obesity in later life. These outcomes support a role of lipid
matrix beyond the FA composition in dietary lipid quality in
early life linked to later life health.
The mechanism(s) underlying the reduction in fat accumulation
by early feeding with the Nuturis® diet is not completely clear.
Table 2. Primer sequences
Gene name NCBI reference number Forward primer Reverse primer
Leptin NM_008493.3 AGGATGACACCAAAACCCTCAT AGTCCAAGCCAGTGACCCTCT
Mest/peg1 NM_008590.1 TCAGTGACAAGCCGAGACCA GTTGATTCTGCGGTTCTGGAG
Pref1 NM_010052.5 TGCGAGGCTGACAATGTCTG ATGCACTGCCATGGTTCCTT
Reference genes
Canx NM_007597.3 AGAGCTCAGCCTGGATCAATTC TTGTAGTCCTCTCCACACTTATCTGG
Rpl19 NM_009078.2 TTGCCTCTAGTGTCCTCCGC CTTCCTGATCTGCTGACGGG
Rps29 NM_009093.2 AGTCACCCACGGAAGTTCGG GTCCAACTTAATGAAGCCTATGTCCTT
Mest/Peg1, mesoderm-specific transcript/paternal expressed gene 1; Pref1, preadipocyte factor 1; Canx, calnexin; Rpl19, ribosomal protein gene L19;
Rps29, ribosomal protein S29.
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As food intake between groups was comparable, differences in
food intake cannot explain the observed adult phenotype. The
structural aspects of the Nuturis® concept, which bring its nutrient
matrix closer to the HM structure, may affect digestion and
absorption, and thereby modulate the postprandial response and
FA metabolism(16). We hypothesise that differences in post-
prandial lipid handling may programme metabolic homoeostasis
and energy balance. This could impact the development and
function of metabolic organs including intestine, pancreas, liver,
brain and WAT, and thereby inﬂuence later life metabolic health.
Previous studies have indeed shown that the lipid structure
impacts gastric emptying, lipid absorption and digestion kinetics
as well as the postprandial handling of lipids(21,22). For example, in
adult rats, HM-derived lipid droplets coated by MFGM alters the
TAG appearance compared with small droplets with proteins at
the interface(28). It clearly shows the importance of lipid droplet
size as well as the nature of the surface coating, both impacting
physical digestion and absorption rate. In general, lipids will either
be targeted for β-oxidation or stored in WAT depending on these
differences in kinetics and metabolic fate. Clearly, in obese peo-
ple, lipid handling has been favoured towards lipid storage instead
rather than towards β-oxidation(29). Absorption and digestion
kinetics are different between adults and infants related to the
digestive immaturity of the infant(30,31). The latter provides the
possibility for lipids to be a major source of energy as well as
education for the developing metabolism, affecting growth and
metabolic development. We speculate that in particular the
combination of lipid droplet size and its surface composition of PL
originating from MFGM fraction as present in Nuturis® during




































































































































Fig. 2. Relative body composition at postnatal day (PN) 98. (A) Body-weight gain. (B) Lean body mass. (C) Fat mass gain. (D) Relative percentage fat mass.
Mice were fed different infant milk formula concepts, including small (S; n 12) v. large (L; n 12) lipid droplets, or with milk fat globule membrane as lipid droplet coating
(coating) and challenged with a Western-style diet from PN42 till PN98. The reference (REF) group is the unchallenged (REF; n 12). Values are means, with their
standard errors. a,b,c Mean values with unlike letters were significantly different (P< 0·05). S=Nutrilon; Lcoating=Nuturis®.
Table 3. Average weight of white adipose tissue (WAT) depots and organs of mice fed different infant milk formula diets and
challenged with a Western-style diet from PN42 till PN98
(Mean values with their standard errors; n 12 per diet group)
S L Scoating Lcoating
Mean SEM Mean SEM Mean SEM Mean SEM
WAT
Epididymal (mg) 998a 85 958a,b 107 989a 118 633b 77
Retroperitoneal (mg) 310 30 313 38 319 44 204 30
Inguinal (mg) 459a,b 31 498a,b 47 552a 66 338b 36
Perirenal (mg) 49a,b 7·2 60a 10 59a,b 9·6 28b 9·2
Liver (g) 1·4a 0·0 1·1b 0·1 1·2b 0·0 1·2a,b 0·0
Pancreas (mg) 153 6·1 170 12 164 7·1 147 6·5
Musculus tibialis (mg) 49 1·5 49 1·4 49 0·9 49 1·8
Brain (mg) 423 4·3 417 6·7 421 4·2 406 12
S, small droplets; L, large droplets; Scoating, small droplets coated by milk fat globule membrane (MFGM); Lcoating, large droplets coated by MFGM.
a,b Mean values with unlike superscript letters were significantly different (P<0·05).
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life (metabolic) health. As a consequence, the adult metabolic
homoeostasis may be more ﬂexible to handle various lifestyle
challenges, for example, a diet higher in (SFA) fats. Fat oxidation
could be one of the targets of programming, but others are also
possible, including glucose homoeostasis, fat absorption kinetics
and postprandial physiology.
Future research is required to assess whether differential
digestion and absorption kinetics induced by lipid structure of
Nuturis® (Lcoating) indeed underlie the long-term effects found
in the present study. Recent imaging experiments comparing
Nuturis® lipid droplets indeed conﬁrm the notion that the lipid
structure is closer to that observed in HM (Gallier et al.,
unpublished results).
One of the possible mechanisms that could contribute to the
observed protective effect of Nuturis® on body fat accumulation
is reduced lipid storage capacity and a decline in lipogenesis in
WAT. Previously, we found a reduced expression of PPARγ
(related to lipogenesis) in mice fed Nuturis® compared with
mice fed control diet (S) before the WSD challenge(23). Indeed,
WAT development during the PN period may determine the
size and function of WAT in later life(32). The total adipocyte
number increases in early life and a constant fat cell number is
only established by early adulthood(33,34). FM changes in
adulthood are mostly driven by changes in adipocyte cell
volume and not cell number(34). Mest/peg1, a marker for adi-
pocyte size, is highly expressed in WAT and inhibits the Wnt
signalling pathway, which stimulates the differentiation of stem
cells in preadipocytes(34–38). We found that early-life feeding
with Nuturis® could lower the expression of mest/peg1 in RP
WAT, although not signiﬁcant compared with our control diet
containing small lipid droplets with or without MFGM coating.
This observation indeed supports the reduced FM seen in
Nuturis®-fed mice. FM also strongly corresponded with leptin
expression levels in RP WAT, particularly in Nuturis®-fed mice
(Lcoating; R 0·732, P= 0·000). Plasma leptin concentrations are
positively correlated to FM in both humans and rodents and
implicated in energy homoeostasis(39–41). Detailed analysis of
adipose tissue to gain further insights into adipose tissue func-
tion is one of the approaches needed to understand the
underlying mechanisms for the observed protective effect of
Nuturis® feeding in early life. The expression of genes impli-
cated in lipogenesis and lipolysis cannot be easily differentiated
from the present study design, because the observed effect is a
combination between programming and a WSD effect. Rather, a
study with a speciﬁc experimental design is required to obtain
mechanistic information on lipogenesis and lipolysis. Studies to
obtain more detailed information on lipogenesis and lipid sto-
rage in WAT as well as in vivo energy expenditure are needed
to determine whether these possibilities are indeed the under-
lying mechanisms.
MFGM supplementation to IMF has been proven to be safe
and well tolerated(42). Recent studies by Timby et al.(43) suggest
beneﬁcial effects of adding MFGM lipid products to IMF in
infants on speciﬁc immune and cognitive outcomes. Cognitive
development and serum cholesterol concentrations in MFGM-
enriched formula-fed infants were closer to breast-fed infants at
12 months of age(19,44). Although it was hypothesised that these











































































































Fig. 3. mRNA expressions in arbitrary units (AU) of leptin (A), mesoderm-specific transcript/paternal expressed gene 1 (mest/peg1) (B) and preadipocyte factor 1
(pref1) (C) in retroperitoneal (RP) white adipose tissue (WAT) of mice fed different infant milk formula concepts, including small (S) v. large (L) lipid droplets, or with milk
fat globule membrane as lipid droplet coating (coating) and challenged with a Western-style diet from postnatal (PN) 42 till PN98. Sample size is 12, 11, 10, 12,
respectively. The reference (REF) group is the unchallenged (REF; n 10). Values are means, with their standard errors. a,b,c Mean values with unlike letters were
significantly different (P< 0·05). S=Nutrilon; Lcoating=Nuturis®.
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metabolism, as well as on the risk for CVD(20). No effects were
reported on growth or long-term health outcomes. In a recently
published editorial, Greer & Kleinman(45) raised the question
whether adding MFGM combined with lower protein and
energy contents to IMF could bring IMF closer to HM compo-
sition and health beneﬁts attributed to breast-feeding. Our
results clearly show that adding MFGM as a coating to current
IMF containing small lipid droplets, only the combination of
a large lipid droplet size and the MFGM coating showed
beneﬁcial effects on later life FM gain. Notably, in the studies by
Timby et al.(19,20,43) MFGM was added to an IMF that was lower
in both energy as well as protein compared with the IMF used
to construct the rodent diets. Therefore, the observed effects
found in Timby et al. could also, at least in part, be explained by
the combination of these nutrient composition and energy dif-
ferences instead of the MFGM supplementation alone. Clinical
studies testing the effect of Nuturis® on growth and body
composition development are currently on-going (clinical trial
registry NCT01609634 and the Dutch Trial Register NTR3683).
Although we found reduced adiposity in adult life after feeding
a diet with an altered lipid structure in early life, we did not
observe signiﬁcant improvements in metabolic parameters as far
as tested. This could be explained, at least in part, by the fact that
the WSD challenge was rather mild as it did not generate major
disturbances in plasma lipid or glucose homoeostasis compared
with the unchallenged REF group, nor resulted in hyperphagia or
overt obesity. The choice of this relatively mild obesogenic diet
was based on the assumption that this would mimick a modern
Western lifestyle more closely. Indeed, the WSD challenge in our
model did not induce hyperphagia as is commonly seen with
more extremeWSD diets in the literature(46,47). To assess whether
the Nuturis® diet may protect against the development of
metabolic risk factors, it would be interesting to extend the
duration of the mild WSD challenge and/or use a more severe
dietary challenge in future studies.
In conclusion, a diet containing the combination of large lipid
droplets and a coating with MFGM mimicking the lipid droplet
architecture as present in mammalian milk prevents body fat
accumulation when challenged with a moderate WSD during
adolescence and adulthood. These observations conﬁrm the
notion that the complex lipid structure beyond the composition
of lipids may be an important factor in the early diet that
determines growth and development of body composition and
impacts long-term (metabolic) health. Future experimental and
clinical studies are required to conﬁrm the protective effect of
this concept in humans and to gain more detailed insights about
the underlying mechanisms.
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